ETFIQData as of Nov 19, 2026. · etfiq.com/funds/roe

ROE Fact Sheet: Astoria US Equal Weight Quality Kings ETF

Share
$39.15
close, Nov 20, 2026

Over the year to Nov 19, 2026, ROE returned +20.7% in total and charged 0.49% a year.

1-year total return
+19.4%
VOO +7.2% to Nov 20, 2026
Expense ratio
0.49%
a year
Net flow, 12 months to Aug 31, 2026
+$59.1m
monthly N-PORT basis to Aug 31, 2026

Growth of $10,000, 1 year

ROE $12,068 +20.7% · VOO $11,147 +11.5% · Total return, distributions reinvested, Nov 19, 2025 to Nov 19, 2026.

Returns

WindowTotal return
1 month−9.8%
3 months−10.2%
Year to date+11.8%
1 year+19.4%
3 years+67.7%

Total return, distributions reinvested, each window to Nov 20, 2026.

Ten largest positions

HoldingWeight
Palantir Technologies Inc1.69%
Adobe Inc1.45%
Halozyme Therapeutics Inc1.44%
Tenet Healthcare Corp1.40%
Microsoft Corp1.39%
Fox Corp1.34%
Newmont Corp1.29%
APA Corp1.27%
ResMed Inc1.19%
Motorola Solutions Inc1.17%

ROE top ten by weight, 13.6% of the fund, of its 98 equity positions, from the holdings filed for Aug 31, 2026.

Facts

Equity fund · Actively managed · First traded Aug 1, 2023 · Benchmark S&P 500 Total Return Index, measured by VOO, which tracks the same index

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, ROE Fact Sheet: Astoria US Equal Weight Quality Kings ETF. Data as of Nov 19, 2026. https://etfiq.com/funds/roe/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/roe.